EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate‐to‐Severe Acne

Nello Tommasino iD, Maria Carmela Annunziata, Luca Potestio iD, Maddalena Napolitano iD

Journal of Cosmetic Dermatology · 2026-04 · 25 (4)

DOI: 10.1111/jocd.70812 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 31.03.2026. Verfasst von Nello Tommasino und 3 weiteren Autor:innen. Beteiligte Einrichtung: Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. Hauptthemen laut MEDLINE: Acne Vulgaris, Dermatologic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acne vulgaris is a common inflammatory skin disorder with significant psychosocial impact. While isotretinoin remains the gold standard for moderate‐to‐severe cases, its adverse effects and teratogenicity underscore the need for alternative systemic therapies.

Objective

To review emerging systemic treatments for acne beyond isotretinoin, evaluating their efficacy, safety, and potential clinical applications.

Methods

A narrative review was conducted through PubMed, Scopus, and Web of Science, including studies from January 2015 to June 2025. Eligible publications focused on systemic treatments for moderate‐to‐severe acne, excluding topical‐only and non‐peer‐reviewed studies.

Results

Promising alternatives include the narrow‐spectrum antibiotic sarecycline, hormonal agents such as spironolactone and combined oral contraceptives, and metformin in patients with polycystic ovary syndrome. Biologic therapies, phosphodiesterase‐4 inhibitors, oral probiotics, and novel agents like montelukast and CAMP factor vaccines are also under investigation. These treatments show varying degrees of efficacy and improved safety profiles, but most lack head‐to‐head comparisons with isotretinoin.

Conclusion

Several systemic options beyond isotretinoin have emerged, showing potential in specific subgroups or as adjunctive therapies. However, further large‐scale comparative studies are needed to define their roles within evidence‐based acne management algorithms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acne VulgarisDermatologic AgentsHumansIsotretinoinSeverity of Illness IndexAnti-Bacterial AgentsFemaleMetforminSpironolactoneProbioticsContraceptives, Oral, CombinedPhosphodiesterase 4 InhibitorsMinocyclineTreatment OutcomeBiological TherapyTetracyclines

Stichwörter der Autor:innen

acnemanagementsystemic therapies

Substanzen

IsotretinoinDermatologic AgentsAnti-Bacterial AgentssarecyclineMetforminSpironolactoneContraceptives, Oral, CombinedPhosphodiesterase 4 InhibitorsMinocyclineTetracyclines

Autor:innen und Institutionen

  • Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

ORCID-Profile: Nello Tommasino, Luca Potestio, Maddalena Napolitano

Zitieren

APA

Tommasino, N., Annunziata, M. C., Potestio, L., & Napolitano, M. (2026). Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate‐to‐Severe Acne. Journal of Cosmetic Dermatology, 25(4). https://doi.org/10.1111/jocd.70812

Vancouver

Tommasino N, Annunziata MC, Potestio L, Napolitano M. Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate‐to‐Severe Acne. Journal of Cosmetic Dermatology. 2026;25(4). doi:10.1111/jocd.70812

BibTeX
@article{Tommasino2026,
  author = {Tommasino, Nello and Annunziata, Maria Carmela and Potestio, Luca and Napolitano, Maddalena},
  title = {Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate‐to‐Severe Acne},
  journal = {Journal of Cosmetic Dermatology},
  year = {2026},
  volume = {25},
  number = {4},
  doi = {10.1111/jocd.70812}
}
Kostenlos starten →